Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5862)
All Articles published online
|
Dec 12, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen LP, Zhao J, Du Y, Han YF, Su T, Zhang HW, Cao GW. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma. World J Virol 2012; 1(6): 174-183 [PMID: 24175223 DOI: 10.5501/wjv.v1.i6.174] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v1/i6/174.htm |
| Number | Citing Articles |
| 1 |
Vahdat Poortahmasebi, Reza Malekzadeh, Ghodratollah Montazeri, Ehsan Fakhari, Mehdi Norouzi, Azam Khamseh, Masoud Mahmoodi Karkhaneh, Ahmad Tavakoli, Seyed Mohammad Jazayeri. Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features. Jundishapur Journal of Microbiology 2015; 8(9) doi: 10.5812/jjm.20262
|
| 2 |
Sofia Vitor, Rui Tato Marinho, José Gíria, José Velosa. An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in Portugal. BMC Research Notes 2016; 9(1) doi: 10.1186/s13104-016-1879-8
|
| 3 |
Yutaka Furutani, Mariko Toguchi, Yumi Shiozaki-Sato, Xian-Yang Qin, Etsuko Ebisui, Shoko Higuchi, Masayuki Sudoh, Harukazu Suzuki, Nobuaki Takahashi, Koichi Watashi, Takaji Wakita, Hideaki Kakeya, Soichi Kojima, Kyun-Hwan Kim. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes. PLOS ONE 2019; 14(6): e0216139 doi: 10.1371/journal.pone.0216139
|
| 4 |
Jian Sun, Huiguo Ding, Guofeng Chen, Guiqiang Wang, Lai Wei, Jiming Zhang, Qing Xie, Mobin Wan, Hong Tang, Shijun Chen, Zhiliang Gao, Yuming Wang, Dazhi Zhang, Wenxiang Huang, Jifang Sheng, Qin Ning, Dongliang Yang, Jian Lu, Chen Pan, Yuxiu Yang, Jue Wang, Chuanzhen Sun, Qixin Wang, Jinlin Hou. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0981-5
|
| 5 |
Wei Luo, Junxia Wang, Dengfeng Xu, Huili Bai, Yangli Zhang, Yuhong Zhang, Xiaosong Li. Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV in�vitro and in�vivo. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3396
|
| 6 |
Yan Du, Yu-Wei Zhang, Rui Pu, Xue Han, Jian-Ping Hu, Hong-Wei Zhang, Hong-Yang Wang, Guang-Wen Cao. Phosphatase and Tensin Homologue Genetic Polymorphisms and their Interactions with Viral Mutations on the Risk of Hepatocellular Carcinoma. Chinese Medical Journal 2015; 128(8): 1005 doi: 10.4103/0366-6999.155057
|
| 7 |
Yun Wang, Xiaogang Xiang, Liwen Chen, Zhujun Cao, Rebecca Bao, Huijuan Zhou, Weiliang Tang, Jie Lu, Lanyi Lin, Qing Xie, Shisan Bao, Hui Wang. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy. Oncotarget 2016; 7(36): 58553 doi: 10.18632/oncotarget.10155
|
| 8 |
Grace C Lovett, Tin Nguyen, David M Iser, Jacinta A Holmes, Robert Chen, Barbara Demediuk, Gideon Shaw, Sally J Bell, Paul V Desmond, Alexander J Thompson. Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World Journal of Hepatology 2017; 9(1): 48-56 doi: 10.4254/wjh.v9.i1.48
|
| 9 |
Fumitaka Suzuki, Yoshiyuki Suzuki, Yoshiyasu Karino, Yasuhito Tanaka, Masayuki Kurosaki, Hiroshi Yatsuhashi, Tomofumi Atarashi, Masanori Atsukawa, Tsunamasa Watanabe, Masaru Enomoto, Masatoshi Kudo, Naoto Maeda, Hiroshi Kohno, Kouji Joko, Kojiro Michitaka, Koichiro Miki, Kazuhiro Takahashi, Tatsuya Ide, Shigetoshi Fujiyama, Tomoko Kohno, Hiroshi Itoh, Sakiyo Tsukamoto, Yuko Suzuki, Yoshiaki Kawano, Wataru Sugiura, Hiromitsu Kumada. Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02008-9
|
| 10 |
Mara Cirone. Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses. Critical Reviews in Biochemistry and Molecular Biology 2021; 56(5): 500 doi: 10.1080/10409238.2021.1934811
|
| 11 |
Yuan Zhuang, Hong Ding, Yue Zhang, Huichuan Sun, Chen Xu, Wenping Wang. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis Indexes. Radiology 2017; 283(3): 873 doi: 10.1148/radiol.2016160131
|
| 12 |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou, Hui Xie. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(2): 129-150 doi: 10.4254/wjh.v15.i2.129
|
| 13 |
Gabriele Ricco, Daniela Cavallone, Chiara Cosma, Gian Paolo Caviglia, Filippo Oliveri, Alessandra Biasiolo, Maria Lorena Abate, Mario Plebani, Antonina Smedile, Ferruccio Bonino, Patrizia Pontisso, Maurizia Rossana Brunetto. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers. Cancer Biomarkers 2018; 21(3): 603 doi: 10.3233/CBM-170551
|
| 14 |
Abubakar Yaro, Svetoslav Martinov, Catherine Johnson. Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative review. Journal of Human Virology & Retrovirology 2023; 10(3): 73 doi: 10.15406/jhvrv.2023.10.00271
|
| 15 |
Senko Tsukuda, Koichi Watashi, Masashi Iwamoto, Ryosuke Suzuki, Hideki Aizaki, Maiko Okada, Masaya Sugiyama, Soichi Kojima, Yasuhito Tanaka, Masashi Mizokami, Jisu Li, Shuping Tong, Takaji Wakita. Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression. Journal of Biological Chemistry 2015; 290(9): 5673 doi: 10.1074/jbc.M114.602540
|
| 16 |
Thomas H. King, Charles B. Kemmler, Zhimin Guo, Derrick Mann, Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Z. Ho, William Delaney, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shikha Shrivastava, Yu-Jin L. Lee, Shyamasundaran Kottilil, Donald Bellgrau, Timothy Rodell, David Apelian, Kim J. Hasenkrug. A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance. PLoS ONE 2014; 9(7): e101904 doi: 10.1371/journal.pone.0101904
|
| 17 |
Wenbin Liu, Guangwen Cao. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99838
|
| 18 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 19 |
Min Zhang, Dexin Wang, Haidong Liu, Hui Li. Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0191-8
|
| 20 |
Jianhui Qu, Zujiang Yu, Qin Li, Yongping Chen, Dedong Xiang, Lin Tan, Chunliang Lei, Wenlin Bai, Hongyan Li, Qinghua Shang, Liang Chen, Xiaoyu Hu, Wei Lu, Zhiqin Li, Da Chen, Xiaodong Wang, Changjiang Zhang, Guangming Xiao, Xun Qi, Jing Chen, Li Zhou, Guofeng Chen, Yonggang Li, Zhen Zeng, Guanghua Rong, Zheng Dong, Yan Chen, Min Lou, Chunping Wang, Yinying Lu, Cuihong Zhang, Yongping Yang. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial. Trials 2014; 15(1) doi: 10.1186/1745-6215-15-438
|
| 21 |
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
|
| 22 |
Enze Jiang, Anna Junjie Shangguan, Shuangshuang Chen, Lin Tang, Shuang Zhao, Zhenghong Yu. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma. Cancer Letters 2016; 379(2): 262 doi: 10.1016/j.canlet.2015.07.016
|
| 23 |
Baihai Jiao, Xuezhen Shi, Yanzhao Chen, Haiyan Ye, Min Yao, Wenxu Hong, Shilin Li, Xiaoqiong Duan, Yujia Li, Yancui Wang, Limin Chen. Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathway. Oncotarget 2017; 8(62): 105923 doi: 10.18632/oncotarget.22510
|
| 24 |
Naveen Ganjoo, Thomas D. Schiano. Disease Recurrence After Liver Transplantation. 2016; : 165 doi: 10.1007/978-1-4939-2947-4_12
|
| 25 |
Shaoyou Qin, Jiangbin Wang, Changyu Zhou, Yan Xu, Yonggui Zhang, Xu Wang, Song Wang. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection. Medicine 2019; 98(38): e17275 doi: 10.1097/MD.0000000000017275
|